Cover Image

Respiratory syncytial virus infection in children with congenital heart disease: global data and interim results of Korean RSV-CHD survey

Respiratory syncytial virus (RSV) is a main cause of hospitalization for bronchiolitis and pneumonia in infants worldwide. Children with hemodynamically significant congenital heart disease (HS-CHD), as well as premature infants are at high risk for severe RSV diseases. Mortality rates for CHD patie...

Full description

Saved in:

Bibliographic Details
Main Author:	Jo Won Jung (Author)
Format:	Book
Published:	Korean Pediatric Society, 2011-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
by: Andrea Gastaldi, et al.
Published: (2021)

Pricey or priceless: cost-effectiveness of respiratory syncytial virus (RSV) prevention in infants
by: Xiao Li, et al.
Published: (2024)

Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series
by: Nienke M Scheltema, MD, et al.
Published: (2017)

The new reporting obligation for Respiratory Syncytial Virus (RSV) in Germany - a critical view
by: Heudorf, Ursel, et al.
Published: (2024)

Respiratory syncytial virus (RSV) disease - new data needed to guide future policy
by: Louis Bont, et al.
Published: (2015)

Airway gene-expression classifiers for respiratory syncytial virus (RSV) disease severity in infants
by: Lu Wang, et al.
Published: (2021)

The cost of care for children hospitalized with respiratory syncytial virus (RSV) associated lower respiratory infection in Kenya
by: Joyce U. Nyiro, et al.
Published: (2024)

Current Insights Into Host Immune Responses to Human Respiratory Syncytial Virus (RSV) and Challenges Towards Efficient Treatments and Vaccines Against RSV
Published: (2020)

Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy
by: Domenico Ponticelli, et al.
Published: (2024)

Serological Survey Of Respiratory Syncytial Virus (RSV) Among Children In Lorin North-Central, Nigeria.
by: Odebisi- Omokanye, et al.
Published: (2018)

Respiratory syncytial virus infection cases in congenital heart disease patients
by: Woo Sup Shim, et al.
Published: (2010)

An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children
by: Simões Eric AF, et al.
Published: (2011)

Perceptions about respiratory syncytial virus (RSV) and attitudes toward the RSV vaccine among the general public in China: A cross-sectional survey
by: Qiang Wang, et al.
Published: (2024)

Respiratory syncytial virus prevention in children with congenital heart disease: who and how?
by: Nam Kyun Kim, et al.
Published: (2011)

Respiratory syncytial virus-associated seizures in Korean children, 2011-2016
by: Teahyen Cha, et al.
Published: (2019)

FACTORS DETERMINING THE HOSPITALISATION DURATION OF STAY IN CHILDREN WITH SEVERE RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN THE RUSSIAN FEDERATION
by: A.A. Baranov, et al.
Published: (2011)

FACTORS DETERMINING THE HOSPITALISATION DURATION OF STAY IN CHILDREN WITH SEVERE RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN THE RUSSIAN FEDERATION
by: A.A. Baranov, et al.
Published: (2011)

Adjustable Algorithmic Tool for Assessing the Effectiveness of Maternal Respiratory Syncytial Virus (RSV) Vaccination on Infant Mortality in Developing Countries
by: Rachel Cevigney, et al.
Published: (2021)

Implementation of the first respiratory syncytial (RSV) immunization campaign with nirsevimab in an autonomous community in Spain
by: Jaime Jesús Pérez Martín, et al.
Published: (2024)

Virus-like Particle Vaccine Expressing the Respiratory Syncytial Virus Pre-Fusion and G Proteins Confers Protection against RSV Challenge Infection
by: Su-Hwa Lee, et al.
Published: (2023)

Identifying climatic drivers of respiratory syncytial virus (RSV) seasonality in Antananarivo, Madagascar, 2011-2021: a sentinel surveillance study
by: Jean-Michel Heraud, et al.
Published: (2024)

Cost-utility analysis of palivizumab in Italy: results from a simulation model in the prophylaxis of respiratory syncytial virus infection (RSV) among high-risk preterm infants
by: Ravasio Roberto, et al.
Published: (2009)

Development of a novel observer-reported outcome measure for the assessment of Respiratory Syncytial Virus (RSV) infection symptoms in pediatric clinical trials
by: Sandy Lewis, et al.
Published: (2018)

Respiratory syncytial virus associated hospitalizations in children with congenital diaphragmatic hernia
by: Bernhard Resch, et al.
Published: (2018)

Evolving Epidemiology of Pediatric Respiratory Syncytial Virus (RSV) Cases Around COVID-19 Pandemic: Impact and Clinical Insights, Retrospective Cohort Study
by: Deema Gashgarey, et al.
Published: (2024)

Implications of gestational age at antenatal care attendance on the successful implementation of a maternal respiratory syncytial virus (RSV) vaccine program in coastal Kenya
by: Joyce U. Nyiro, et al.
Published: (2020)

A latent class analysis of factors influencing preferences for infant respiratory syncytial virus (RSV) preventives among pregnant people in the United States
by: Martine C. Maculaitis, et al.
Published: (2024)

Neonatal priming and infancy boosting with a novel respiratory syncytial virus vaccine induces protective immune responses without concomitant respiratory disease upon RSV challenge
by: Shuren Zhang, et al.
Published: (2020)

Respiratory Syncytial Virus (RSV) Hospitalizations in the Elderly in a Tertiary Care Hospital in Southern Italy as a Useful Proxy for Targeting Vaccine Preventive Strategies
by: Francesca Centrone, et al.
Published: (2024)

A phase 2, randomized, double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab and palivizumab administered in the same season
by: Griffin M Pamela, et al.
Published: (2010)

Respiratory syncytial virus-related hospitalization in premature infants without bronchopulmonary dysplasia: subgroup efficacy analysis of the IMpact-RSV trial by gestational age group
by: Notario G, et al.
Published: (2014)

Identification of miRNA-mRNA Crosstalk in Respiratory Syncytial Virus- (RSV-) Associated Pediatric Pneumonia through Integrated miRNAome and Transcriptome Analysis
by: Xu Zhang, et al.
Published: (2020)

Chapter 5 Respiratory Syncytial Virus
by: Jha, Akhilesh
Published: (2016)

Chapter 5 Respiratory Syncytial Virus
by: Jha, Akhilesh
Published: (2016)

Human Respiratory Syncytial Virus Infection
Published: (2011)

Recommendations of the Spanish Society of Pediatric Cardiology and Congenital Heart Diseases for the prevention of respiratory syncytial virus infections with nirsevimab in pediatric cardiology
by: Constancio Medrano López, et al.
Published: (2024)

Does Prophylaxis Against Respiratory Syncytial Virus Infection Affect the Weight Percentiles of Infants with Hemodynamically Significant Congenital Heart Disease?
by: Ali Orgun, et al.
Published: (2021)

Incidence of respiratory syncytial virus infection in children with congenital heart disease undergoing immunoprophylaxis with palivizumab in Pará state, north region of Brazil
by: Roseane Porfírio de Souza, et al.
Published: (2019)

The effect of palivizumab prophylaxis on respiratory syncytial virus-associated hospitalizations in infants with congenital diaphragmatic hernia
by: Pei-Lan Shao
Published: (2018)

Patient equity and respiratory syncytial virus Immunoprophylaxis
by: H. Cody Meissner
Published: (2019)